openPR Logo
Press release

DPP IV Inhibitors Market: Latest Innovations, Drivers and Industry Key Events 2015 - 2021

07-26-2017 01:38 PM CET | Health & Medicine

Press release from: Persistence Market Research

DPP IV Inhibitors Market: Latest Innovations, Drivers

DPP IV inhibitors are a class of hypoglycemic agents that block the enzyme named dipeptidyl peptidase IV. Dipeptidyl peptidase IV enzyme break down the proteins that are responsible for stimulating the insulin producing cells that slows down gastric secretion. Proteins can activate the release of insulin and can control the blood sugar level if DPP IV is inhibited in our body.

Get access to full summary @: http://www.persistencemarketresearch.com/market-research/dpp-iv-inhibitors-market.asp

Moreover, DPP IV inhibitors restrict the formation of glucagon, a hormone that increases blood glucose level and thereby control the glucose levels in the body. DPP IV inhibitors are widely utilized as a treatment for type 2 diabetes. Sitagliptin, vildagliptin, saxagliptin and linagliptin are included in the drug class DPP IV. Nasopharyngitis, headache, nausea and hypersensitivity are some of the adverse effects due to the utilization of DPP IV.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/5453

Increasing prevalence of type 2 diabetes is a major public health concern worldwide. National Centre for Biotechnology Information in 2011 stated that in the U.S. more than 8% of the total population is diagnosed with diabetes. Diabetes is associated with a number of complications that includes cardiovascular disease, nephropathy, retinopathy, and neuropathy. Thus, the above mentioned factors derives the global DPP IV inhibitors market. However, the cost for DPP IV inhibitors is very high that might hinder the global DPP IV inhibitors market.

Geographically, North America and Europe dominates the global market for DPP IV inhibitors due to high prevalence rate and rising awareness among people about the DPP IV inhibitors. Asia – Pacific is considered as a fastest growing market due to increasing obese population.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/5453

Various key players contributing to the global DPP IV inhibitors market comprises Arisaph Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Eli Lilly And Company, Bristol-Myers Squibb, Merck & Co, Inc., AstraZeneca Plc, Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Company Limited and Novartis AG.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release DPP IV Inhibitors Market: Latest Innovations, Drivers and Industry Key Events 2015 - 2021 here

News-ID: 642377 • Views:

More Releases from Persistence Market Research

Schizophrenia Treatment Market Set to Expand from US$8.8Bn in 2026 to US$12.1Bn by 2033 - Persistence Market Research
Schizophrenia Treatment Market Set to Expand from US$8.8Bn in 2026 to US$12.1Bn …
The schizophrenia treatment market represents a critical segment within the global mental health therapeutics landscape, addressing a chronic and severe psychiatric disorder that affects millions of individuals worldwide. Schizophrenia is characterized by hallucinations, delusions, cognitive impairment, and emotional dysregulation, requiring long-term and often lifelong treatment. The market primarily revolves around pharmacological interventions, supported by psychosocial therapy, digital tools, and structured care delivery models. With improved diagnostic capabilities, expanding access to
Hemoglobinopathy Market to Reach US$1,259.9Mn by 2033 from US$888.6Mn in 2026 at 5.1% CAGR - Persistence Market Research
Hemoglobinopathy Market to Reach US$1,259.9Mn by 2033 from US$888.6Mn in 2026 at …
The hemoglobinopathy market represents a vital segment of the global diagnostics and healthcare landscape, addressing inherited blood disorders that significantly impact public health worldwide. Hemoglobinopathies, including sickle cell disease, thalassemia, and other abnormal hemoglobin variants, are among the most common genetic disorders globally. These conditions affect millions of individuals either as patients or carriers and often require lifelong monitoring, early diagnosis, and continuous clinical management. As healthcare systems increasingly prioritize
Edible Water Pods Market to Reach US$285.9 Million by 2033 - Persistence Market Research
Edible Water Pods Market to Reach US$285.9 Million by 2033 - Persistence Market …
The edible water pods market represents a rapidly emerging segment within the sustainable packaging and alternative beverage solutions industry. Edible water pods are small, biodegradable, and edible capsules typically made from seaweed derived materials or other natural polymers that encapsulate drinking water or flavored liquids. These pods are designed to reduce single use plastic waste while offering a novel and convenient hydration format. As concerns around plastic pollution intensify globally,
Voltage Sag Protector Market Gains Momentum with US$ 740.6 Mn - Persistence Market Research
Voltage Sag Protector Market Gains Momentum with US$ 740.6 Mn - Persistence Mark …
The voltage sag protector market has gained significant attention in recent years due to the growing dependence of modern industries and commercial facilities on stable and uninterrupted power supply. Voltage sags, also known as voltage dips, are short duration reductions in voltage levels that can severely impact sensitive electrical and electronic equipment. These disturbances often occur due to grid switching operations, short circuits, lightning strikes, or the starting of heavy

All 5 Releases


More Releases for DPP

Digital Product Passports (DPP) Market Future Business Opportunities 2025-2032
The Digital Product Passports (DPP) market is rapidly evolving as industries seek innovative ways to enhance transparency and sustainability across supply chains. With increasing regulatory pressure and consumer demand for environmentally friendly products, companies are leveraging digital solutions to provide comprehensive product information. The Global Digital Product Passports Market size is estimated to be valued at USD 1.2 billion in 2025 and is expected to reach USD 3.5 billion by
Digital Product Passports (DPP) Market Trends and Innovations for 2025
The Digital Product Passports (DPP) market is rapidly evolving, driven by the increasing need for transparency and sustainability in product lifecycles. As consumers become more conscious of environmental impacts and demand greater accountability from brands, DPPs provide a comprehensive solution by offering detailed information about a product's origin, materials, and end-of-life options. This emerging technology encapsulates a wide range of applications across various industries, including textiles, iron and steel, batteries,
Game-Changers in Diabetes: DPP-4 Inhibitors Market Insights
The Business Research Company recently released a comprehensive report on the Global Dipeptide Peptidase 4 Inhibitors Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get
DPP IV Inhibitors (DPP-4 Inhibitors) Market to Witness Huge Growth by 2029 | Ast …
The DPP IV Inhibitors (DPP-4 Inhibitors) research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the DPP IV Inhibitors (DPP-4 Inhibitors) research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving
Global DPP IV Inhibitor Market Research Report Forecast 2017 to 2021
Report Hive Market Research Released a New Research Report of 120 pages on Title " Global DPP IV Inhibitor Market Research Report Forecast 2017 to 2021 "with detailed Analysis, Forecast and Strategies. The Global DPP IV Inhibitor Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the DPP IV Inhibitor industry overview with growth analysis and historical & futuristic cost, revenue, demand and
DPP IV Inhibitors Market Set to Surge Significantly by 2021
DPP IV inhibitors are a class of hypoglycemic agents that block the enzyme named dipeptidyl peptidase IV. Dipeptidyl peptidase IV enzyme break down the proteins that are responsible for stimulating the insulin producing cells that slows down gastric secretion. Proteins can activate the release of insulin and can control the blood sugar level if DPP IV is inhibited in our body. Moreover, DPP IV inhibitors restrict the formation of glucagon,